SIGN2014EN
SIGN 122: Prevention and Management of Venous Thromboembolism
Zusammenfassung
Prevention and management of venous
thromboembolism
A national clinical guideline
December 2010
Updated October 2014
122
KEY TO EVIDENCE STATEMENTS AND GRADES OF RECOMMENDATIONS
LEVELS OF EVIDENCE
1
++
High quality meta-analyses, systematic reviews of RCTs, or RCTs with a very low risk of bias
1
+
Well conducted meta-analyses, systematic reviews, or RCTs with a low risk of bias
1
-
Meta-analyses, systematic reviews, or RCTs with a high risk of bias
2
++
High quality systematic reviews
Kerninformationen
More information on accreditation can be viewed at
www.evidence.nhs.uk
NHS Quality Improvement Scotland (NHS QIS) is committed to equality and diversity and assesses all its publications for likely
impact on the six equality groups defined by age, disability, gender, race, religion/belief and sexu...
The review history,
and any updates to the guideline in the interim period, will be noted in the review report, which is
available in the supporting material section for this guideline on the SIGN website: www.sign.ac.uk
Citation text
Scottish Intercollegiate Guidelines Network (SIGN). Prevention ...
This applies particularly to patients with medical illnesses,
1
but also to those
admitted to surgical wards.
2
Venous thromboembolism is likely to be an escalating public
health problem due to the prominence of age as a risk factor (see Table 1, section 3.2) and the
increasing age of the popul...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
SIGN2021
SIGN 163: Prevention and management of venous thromboembolism in COVID-19
UKKA2025
UKKA Clinical Practice Guideline: Anticoagulation for Venous Thromboembolism in Adults with Advanced Kidney Disease (October 2025)
Chinese Medical Association2024
Chinese Expert Consensus on Prevention, Diagnosis, and Management of VTE
Cochrane2020
Cochrane Review: Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Cochrane2024
Cochrane Review: Standard- versus extended-duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients
Cochrane2021
Cochrane Review: Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period
Cochrane2019
Cochrane Review: Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery
Cochrane2021